Active Motif
Private Company
Total funding raised: $20M
Overview
Active Motif is a leading provider of research tools in the rapidly growing field of epigenetics, operating as a private, revenue-generating company. It has established a strong reputation over two decades for high-quality antibodies, innovative assay kits, and custom service capabilities like ChIP-seq. While not a therapeutic developer, its platform enables critical discovery research across academia and industry, positioning it as an essential enabler in the genomics and drug discovery value chain. The company's success is tied to the continued expansion of epigenetics research and the demand for reliable, standardized research reagents.
Technology Platform
Integrated platform for epigenetics research, including high-specificity antibodies, assay kits (e.g., ChIP-seq), and custom services for chromatin analysis and next-generation sequencing.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Competes with large reagent conglomerates like Thermo Fisher Scientific and Merck Millipore, as well as focused antibody companies like Cell Signaling Technology and Abcam. Differentiates through deep specialization in epigenetics, rigorous antibody validation, and a strong integrated service model for ChIP-seq.